Hypera HYPMY Stock
Hypera Price Chart
Hypera HYPMY Financial and Trading Overview
Hypera stock price | 5.43 USD |
Previous Close | 9.37 USD |
Open | 9.5 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 9.45 - 9.6 USD |
52 Week Range | 6.81 - 9.6 USD |
Volume | 2.88K USD |
Avg. Volume | 5.34K USD |
Market Cap | 5.99B USD |
Beta (5Y Monthly) | 0.217808 |
PE Ratio (TTM) | 17.218182 |
EPS (TTM) | 0.51 USD |
Forward Dividend & Yield | 0.23 (2.46%) |
Ex-Dividend Date | April 5, 2023 |
1y Target Est | N/A |
HYPMY Valuation Measures
Enterprise Value | 13.85B USD |
Trailing P/E | 17.218182 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.7724421 |
Price/Book (mrq) | 0.55457956 |
Enterprise Value/Revenue | 1.786 |
Enterprise Value/EBITDA | 5.297 |
Trading Information
Hypera Stock Price History
Beta (5Y Monthly) | 0.217808 |
52-Week Change | 27.62% |
S&P500 52-Week Change | 20.43% |
52 Week High | 9.6 USD |
52 Week Low | 6.81 USD |
50-Day Moving Average | 7.86 USD |
200-Day Moving Average | 8.26 USD |
HYPMY Share Statistics
Avg. Volume (3 month) | 5.34K USD |
Avg. Daily Volume (10-Days) | 6.13K USD |
Shares Outstanding | 632.23M |
Float | 403.42M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0.034% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.231 |
Trailing Annual Dividend Yield | 13.14% |
5 Year Average Dividend Yield | 374.00% |
Payout Ratio | 0.4559 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 21.77% |
Operating Margin (ttm) | 32.39% |
Gross Margin | 63.32% |
EBITDA Margin | 33.72% |
Management Effectiveness
Return on Assets (ttm) | 7.31% |
Return on Equity (ttm) | 16.37% |
Income Statement
Revenue (ttm) | 7.75B USD |
Revenue Per Share (ttm) | 12.26 USD |
Quarterly Revenue Growth (yoy) | 13.70% |
Gross Profit (ttm) | 4.76B USD |
EBITDA | 2.61B USD |
Net Income Avi to Common (ttm) | 1.69B USD |
Diluted EPS (ttm) | 0.55 |
Quarterly Earnings Growth (yoy) | -2.70% |
Balance Sheet
Total Cash (mrq) | 1.09B USD |
Total Cash Per Share (mrq) | 1.72 USD |
Total Debt (mrq) | 9B USD |
Total Debt/Equity (mrq) | 83.16 USD |
Current Ratio (mrq) | 1.96 |
Book Value Per Share (mrq) | 17.076 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.03B USD |
Levered Free Cash Flow (ttm) | -662532224 USD |
Profile of Hypera
Country | United States |
State | SP |
City | São Paulo |
Address | Av. Magalhães de Castro, 4800 |
ZIP | 05676-120 |
Phone | 55 11 3627 4206 |
Website | https://www.hyperapharma.com.br |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.
Q&A For Hypera Stock
What is a current HYPMY stock price?
Hypera HYPMY stock price today per share is 5.43 USD.
How to purchase Hypera stock?
You can buy HYPMY shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hypera?
The stock symbol or ticker of Hypera is HYPMY.
Which industry does the Hypera company belong to?
The Hypera industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hypera have in circulation?
The max supply of Hypera shares is 701.84M.
What is Hypera Price to Earnings Ratio (PE Ratio)?
Hypera PE Ratio is 11.80392200 now.
What was Hypera earnings per share over the trailing 12 months (TTM)?
Hypera EPS is 0.51 USD over the trailing 12 months.
Which sector does the Hypera company belong to?
The Hypera sector is Healthcare.